In summary, this study identifies the MEG3/EZH2/SIRT6 axis and demonstrates its significance in controlling the pathogenesis of NAFLD, specifically, lipogenesis and inflammation. This evidence concerns the gene EZH2 and metabolic dysfunction-associated steatotic liver disease.